Dr. Emu received her B.A. from Harvard University and her M.D. from Johns Hopkins University School of Medicine. She completed an Internal Medicine residency at Beth Israel Deaconess Medical Center and fellowship in Infectious Diseases at the University of California, San Francisco. She remained on faculty at UCSF from 2004 to 2009, studying immune correlates of protection in HIV-infected individuals. Dr Emu then worked as Medical Director in early clinical development at Genentech, Inc in South San Francisco (2009-2012). While at Genentech, she focused on development of novel therapeutic approaches to unmet needs in infectious diseases, inflammation, and oncology.
Dr. Emu joined the Division of Infectious Diseases at Yale School of Medicine in 2013. Her laboratory studies the intersection of chronic viral infection and oncology, with a focus on HIV-associated malignancies. Specifically, she studies the impact of HIV-associated immune dysfunction on carcinogenesis and tumor progression.
|AIDS Clinical Trials Group||Elected Member of the Inflammation Transformative Science Group||2018 - Present|